Severe depression as a neuropsychiatric side effect induced by dolutegravir
Sign Up to like & getrecommendations! Published in 2018 at "HIV Medicine"
DOI: 10.1111/hiv.12538
Abstract: With great interest we have read the recent article by Hoffmann et al. [1], in which an almost 6% discontinuation rate for dolutegravir (DGV) because of neuropsychiatric adverse events was described in a large cohort… read more here.
Keywords: depressive symptoms; depression; dolutegravir; discontinuation ... See more keywords